CVS’s Turnaround Faces Its Next Test

Nephros details integrated water safety platform while expanding in Greater New York and Puerto Rico

Establishment Labs signals $269M-$271M 2026 revenue as minimally invasive approaches 15% of sales

Novavax expects $235M-$275M in 2026 adjusted total revenue while targeting $150M-$200M in 2028 non-GAAP R&D and SG&A

Mueller Water Products targets FY2026 adjusted EBITDA of $367M-$372M while narrowing net sales growth to 2.8%-3.5%